Pricing
  1. US-listed companies
  2. Bio Green Med Solution, Inc.
  3. Financials
  4. Cash from financing

Bio Green Med Solution, Inc.【BGMS】

Market cap
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 20248+822.41%
Dec 31, 20231-71.71%
Dec 31, 20223-86.21%
Dec 31, 202122-26.33%
Dec 31, 202030+666.74%
Dec 31, 20194+796.97%
Dec 31, 20180-97.09%
Dec 31, 201715+123.66%
Dec 31, 20167-39.28%
Dec 31, 201511-10.98%
Dec 31, 201412-95.56%
Dec 31, 2013275+11.05%
Dec 31, 2012247+1.63%
Dec 31, 2011243

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)